Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.62B |
| 2 |
Apple
AAPL
|
+$747M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$655M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$427M |
| 5 |
Walt Disney
DIS
|
+$341M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$2.63B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 3 |
Yum! Brands
YUM
|
+$734M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$558M |
| 5 |
Visa
V
|
+$398M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.59% |
| 2 | Technology | 8.45% |
| 3 | Healthcare | 7.6% |
| 4 | Consumer Discretionary | 6.86% |
| 5 | Energy | 6.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GBT
3401
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $2.04M | ﹤0.01% |
128,859
+104,139
| +421% | +$1.85M |
|
|
SGNT
3402
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $2.04M | ﹤0.01% |
167,978
+51,622
| +44% | +$724K |
|
|
PDLI
3403
PUT
DELISTED
PDL BioPharma, Inc.
PDLI
| $2.04M | ﹤0.01% |
612,200
+597,100
| +3,954% | +$1.86M |
|
|
KITE
3404
PUT
DELISTED
Kite Pharma, Inc.
KITE
| $2.04M | ﹤0.01% |
44,400
-3,800
| -8% | -$184K |
|
3405
CALL
DexCom
DXCM
$32.9B
| $2.04M | ﹤0.01% |
+120,000
| New | +$2M |
|
|
FPRX
3406
CALL
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $2.03M | ﹤0.01% |
+50,000
| New | +$1.72M |
|
|
TIER
3407
DELISTED
TIER REIT, Inc.
TIER
| $2.03M | ﹤0.01% |
151,111
+58,157
| +63% | +$820K |
|
|
SUNE
3408
CALL
DELISTED
SUNEDISON, INC COM
SUNE
| $2.03M | ﹤0.01% |
3,758,900
+1,889,700
| +101% | +$4.35M |
|
3409
Schwab US Mid-Cap ETF
SCHM
$14.7B
| $2.03M | ﹤0.01% |
150,000
-846
| -0.6% | -$10.7K |
|
3410
PUT
Kohl's
KSS
$2.28B
| $2.03M | ﹤0.01% |
43,500
-696,400
| -94% | -$32.7M |
|
|
GHDX
3411
DELISTED
Genomic Health, Inc.
GHDX
| $2.03M | ﹤0.01% |
81,866
+51,635
| +171% | +$1.42M |
|
|
HEES
3412
DELISTED
H&E Equipment Services
HEES
| $2.02M | ﹤0.01% |
115,312
+47,903
| +71% | +$694K |
|
3413
PUT
PVH
PVH
$4.09B
| $2.02M | ﹤0.01% |
20,400
-382,600
| -95% | -$30.1M |
|
3414
PUT
Stellantis
STLA
$21.3B
| $2.02M | ﹤0.01% |
252,255
-870,421
| -78% | -$6.29M |
|
3415
Dr. Reddy's Laboratories
RDY
$10.1B
| $2.01M | ﹤0.01% |
222,825
-906,405
| -80% | -$8.1M |
|
3416
PUT
Melco Resorts & Entertainment
MLCO
$2.17B
| $2.01M | ﹤0.01% |
121,900
-62,200
| -34% | -$944K |
|
|
JMBA
3417
DELISTED
Jamba, Inc.
JMBA
| $2.01M | ﹤0.01% |
162,860
+3,300
| +2% | +$42K |
|
3418
Icon
ICLR
$12.2B
| $2.01M | ﹤0.01% |
26,741
+10,612
| +66% | +$744K |
|
3419
Lands' End
LE
$382M
| $2.01M | ﹤0.01% |
78,653
-38,795
| -33% | -$910K |
|
3420
Hope Bancorp
HOPE
$1.81B
| $2M | ﹤0.01% |
132,041
+37,890
| +40% | +$567K |
|
3421
Zillow
ZG
$8.19B
| $2M | ﹤0.01% |
78,422
-23,518
| -23% | -$524K |
|
3422
iShares MSCI Kokusai Fund
TOK
$252M
| $2M | ﹤0.01% |
38,623
-77,544
| -67% | -$3.82M |
|
3423
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.8B
| $2M | ﹤0.01% |
22,901
-40,803
| -64% | -$3.33M |
|
|
MLNX
3424
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $2M | ﹤0.01% |
36,723
-24,835
| -40% | -$1.15M |
|
3425
CALL
JetBlue
JBLU
$2.35B
| $1.99M | ﹤0.01% |
94,200
-76,900
| -45% | -$1.62M |
|
Similar funds
Goldman Sachs's Q1 2016 Portfolio in Review
As of Q1 2016, Goldman Sachs held 7,717 positions worth $304B, down 4.6% from $319B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $11.3B in Q1 2016, closing 656 positions and reducing 3,244 holdings. Its most notable exit was CHUBB CORPORATION, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Financials at 8.6% of assets, down from 9.2% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Goldman Sachs opened a new position in Welbilt, Inc. worth $36.5M.
- Goldman Sachs's largest Q1 2016 buy was Welbilt, Inc.: 2,476,061 shares worth $36.5M.
- Goldman Sachs added most to Pfizer in Q1 2016, an estimated $1.62B increase.
- Goldman Sachs's biggest Q1 2016 reduction was Zimmer Biomet, cutting an estimated $2.63B.
- Goldman Sachs fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $383M.
- Goldman Sachs's ten largest holdings make up 15% of its $304B portfolio in Q1 2016.
- Goldman Sachs opened 593 new positions and closed 656 in Q1 2016.
- Goldman Sachs's portfolio value fell 4.6% quarter-over-quarter to $304B.
Based on Goldman Sachs's 13F filing for Q1 2016, filed 13 May 2016.